Nevertheless, the number of patients in our cohort does not differ significantly from the numbers reported in previously published data (20, 21), which might be the main reason that the differences were not as pronounced in PRL patients compared to those with Cushing disease or acromegaly, where the impact on metabolic and inflammatory traits is more evident (40, 41). The gene discussed is PRL; the disease is acromegaly.